negative regulation t-cell activation autoimmunity mgat5 n-glycosylation 
t-cell activation requires clustering threshold number t-cell receptors tcrs site antigen presentation number reduced cd28 co-receptor recruitment signalling proteins tcrs- demonstrate deficiency beta1 n-acetylglucosaminyltransferase v mgat5 enzyme n-glycosylation pathway lowers t-cell activation thresholds directly enhancing tcr clustering mgat5-deficient mice showed kidney autoimmune disease enhanced delayed-type hypersensitivity increased susceptibility experimental autoimmune encephalomyelitis recruitment tcrs agonist-coated beads tcr signalling actin microfilament re-organization agonist-induced proliferation enhanced mgat5-/- t cells mgat5 initiates glcnac beta1 branching n-glycans thereby increasing n-acetyllactosamine ligand galectins proteins known modulate t-cell proliferation apoptosis indeed galectin associated tcr complex cell surface interaction dependent mgat5 pre-treatment wild-type t cells lactose compete galectin binding produced phenocopy mgat5-/- tcr clustering data indicate galectin-glycoprotein lattice strengthened mgat5-modified glycans restricts tcr recruitment site antigen presentation dysregulation mgat5 humans may increase susceptibility autoimmune diseases multiple sclerosis 
